share_log

Citigroup Maintains Buy on Exact Sciences, Lowers Price Target to $80

Benzinga ·  May 9 13:54

Citigroup analyst Patrick Donnelly maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $100 to $80.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment